Evidence map›Paper›PMID 42401545›Full record

Trial reportTranslational psychiatry2026

High-order brain interactions during ketamine-induced state changes: A functional marker of response in late-life treatment-resistant depression?

Krisha Shah, Rubén Herzog, Alan C Swann, Brittany O'Brien, Rahul Balakrishnan, Sanjay J Mathew, Nicholas Murphy

Registry-linked trialAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Translational psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02556606 (Ketamine for Treatment Resistant Late-Life Depression), which is not on this map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02556606 phase3completednot on this map

Ketamine for Treatment Resistant Late-Life Depression

TypeinterventionalSponsorVA Office of Research and DevelopmentRan2015 to 2020Enrolled33ConditionsTreatment Resistant Depressive DisorderArmsKetamine, Midazolam
3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Krisha ShahTexas A&M University Naresh K. Vashisht College of Medicine, Department of Psychiatry and Behavioral Sciences, Bryan, TX, USA. krisha.shah@tamu.edu.ORCID http://orcid.org/0009-0008-3059-2226
Rubén HerzogDepartment of Psychology, University of the Balearic Islands, Palma de Mallorca, Spain.ORCID http://orcid.org/0000-0002-3498-5819
Alan C SwannBaylor College of Medicine, Menninger Department of Psychiatry and Behavioral Sciences, Houston, TX, USA.ORCID http://orcid.org/0000-0001-9879-6198
Brittany O'BrienBaylor College of Medicine, Menninger Department of Psychiatry and Behavioral Sciences, Houston, TX, USA.
Rahul BalakrishnanTexas A&M University Naresh K. Vashisht College of Medicine, Department of Psychiatry and Behavioral Sciences, Bryan, TX, USA.ORCID http://orcid.org/0009-0000-5162-193X
Sanjay J MathewTexas A&M University Naresh K. Vashisht College of Medicine, Department of Psychiatry and Behavioral Sciences, Bryan, TX, USA.
Nicholas MurphyTexas A&M University Naresh K. Vashisht College of Medicine, Department of Psychiatry and Behavioral Sciences, Bryan, TX, USA.ORCID http://orcid.org/0000-0003-1805-3082

Funding

CSRD VA I01 CX001205
6 · The paper itself

Abstract

Ketamine is a fast-acting intervention for treatment-resistant depression (TRD), yet only a subset of patients show robust clinical response, and the underlying neural mechanisms remain unclear. High-order interactions (HOI) derived from multivariate information theory provide a framework for examining nonlinear dependencies among brain regions beyond pairwise connectivity. One such metric, the O-information, captures the balance between synergistic and redundant interactions across three or more variables. In this secondary analysis of a randomized, double-blind, midazolam-controlled trial (NCT02556606), we examined EEG-derived HOI in 30 late-life veterans with TRD following a single 40-minute intravenous infusion of ketamine (0.1, 0.25, 0.5 mg/kg; n = 18) or midazolam (0.03 mg/kg; n = 12). Resting state and mismatch negativity data were analyzed at baseline, 1 h, 24 h, and 7 d post-infusion. Ketamine induced temporally dynamic alterations in redundancy-dominant O-info, with maximal effects in the alpha-band at 1 h (Cohen's d = 2.57), attenuation at 24 h that shifted toward the theta-band, and partial resurgence in beta and gamma by Day 7. Linear mixed-effects modeling identified significant group effects across most band x metric families, with the strongest effects in alpha, beta, and gamma redundancy. Greater increases in 24-hour alpha-band redundancy were associated with greater improvement in depressive symptoms at Day 7 (β = 69.31, q = 0.05). HOI metrics also tracked acute dissociative states, with several 24-hour alpha and beta features remaining positively associated with symptom severity after correction. These findings extend prior HOI work in healthy samples to a controlled TRD cohort and suggest that ketamine induces temporally structured reorganization of higher-order brain interactions, with exploratory associations to clinical outcomes.

Indexed as

Antidepressive AgentsBrainDepressive Disorder, Treatment-ResistantKetamineAgedDouble-Blind MethodElectroencephalographyFemaleHumansMaleMidazolamMiddle AgedVeteransAntidepressive AgentsKetamineMidazolam

Identifiers

PMID42401545
PMCPMC13389161

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.